FDA Inspection 1261485 — Mayank Agarwal, M.D.
The FDA completed an inspection of Mayank Agarwal, M.D. on Jan 31, 2025 in Varanasi. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jan 31, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Varanasi (India)
Additional Details
Clinical BA/BE